Harm reduction

Sessions

Plenary session
Poster session
Big debate
Structured session
Workshop
Oral presentation session
Short communication session
Poster guided tour

Alcohol and drug treatment

Health consequences

Digital technology - benefits and risks

Alcohol — Harm reduction

Harm reduction — Prevention

Harm reduction — Public health

Infectious diseases — Harm reduction

Nicotine/tobacco — Harm reduction

Thursday, 08 August

14:00

Emerging findings from a longitudinal evaluation

Police training to reduce drug-related harm in Mexico

14:00

14:05

Harm reduction response to amphetamine users

14:05

14:25

Harm reduction: mobile unti service for PWID in Latvia (launched during HAREACT)

14:25

Wednesday, 23 October

10:50

Understanding and improving health and social outcomes

10:50 to 12:20

Networking zone 3 (N3)

Sanna Rönkä

Alcohol: epidemiology and adolescence

10:50 to 12:20

Central square 2 (C2)

Jorgen G. Bramness

Challenges for harm reduction I

Progress in alcohol research and responses - EUFAS poster session 1

10:50 to 12:20

Guided poster tours room

Colin Drummond

13:20

online registration required

Digital health multi-sector co-ideation game jam

13:20 to 14:50

Futures zone 2 (F2)

Alexandra EstruchAnna SortHeleen RiperMatthijs Blankers

Nicotine harm reduction

13:20 to 14:50

Networking zone 4 (N4)

Ann McNeill

Treatment — challenges, determinants and responses

13:20 to 14:50

Networking zone 3 (N3)

Dominique Lopez

Risk behaviours in context

13:20 to 14:50

Networking zone 2 (N2)

Anja Busse

15:00

Cooperation between harm reduction and law enforcement

Implementation of supervised drug consumption facilities in Zurich: a success story

15:00 to 16:30

Networking zone 2 (N2)

Florian Meyer

Epidemiology of hepatitis C among people who use drugs — Data to inform future planning

15:00 to 16:30

Insights zone 3 (I3)

Vana SypsaJack Stone

16:50

Harm reduction across addictions: Recent results and future directions

16:50 to 18:20

Insights zone 3 (I3)

Karl Mann

online registration required

Digital health multi-sector co-ideation game jam

16:50 to 18:20

Futures zone 2 (F2)

Alexandra EstruchAnna SortPaul Wallace

18:30

Workforce development and training

18:30 to 19:30

Networking zone 3 (N3)

Andrew Bennet

Consumption rooms: overcoming implementation challenges

18:30 to 19:30

Insights zone 4 (I4)

Ricardo Fuertes

Thursday, 24 October

10:50

Methods and approaches to inform drug policy and practice

10:50 to 12:20

Networking zone 4 (N4)

Márya Hynes

Provision, available evidence and gaps

Drug-related interventions in European prisons

10:50 to 12:20

Insights zone 3 (I3)

Linda MontanariCarina Ferreira Borges

Individually-tailored support and education for safer injection

10:50 to 12:20

Networking zone 2 (N2)

Carine Magen

Gender perspectives

10:50 to 12:20

Central square 3 (C3)

Anne Line Bretteville-Jensen

Alcohol perspectives and prevention - EUFAS poster session 2

10:50 to 12:20

Guided poster tours room

Linn Gjersing

13:20

Injecting, risk and reducing harm

13:20 to 14:50

Networking zone 3 (N3)

Thomas Néfau

Focus on prescription drugs I

13:20 to 14:50

Insights zone 3 (I3)

Volker Auwärter

Policy and treatment

13:20 to 14:50

Insights zone 2 (I2)

Matthew Young

Reducing drug-related deaths

13:20 to 14:50

Central square 2 (C2)

Catherine Comiskey

15:00

Treatment interventions

15:00 to 16:30

Networking zone 3 (N3)

Kari Grasaasen

Alcohol: comorbidity, risk and consequences

15:00 to 16:30

Central square 3 (C3)

Geert Dom

Opioid-related deaths and other harms: current and emerging lessons - SSA poster session

15:00 to 16:30

Guided poster tours room

Sarah Welch

16:50

Factors influencing recovery

16:50 to 18:20

Insights zone 3 (I3)

Eilish Gilvarry

New methods

16:50 to 18:20

Central square 2 (C2)

André Noor

18:30

Opioids — current and emerging lessons

18:30 to 19:30

Networking zone 4 (N4)

Roumen Sedefov

Nightlife, festivals and other recreational settings

18:30 to 19:30

Networking zone 3 (N3)

Andrew Bennet

Developing new prevention strategies to improve the situation of clients and employees of harm reduction services

18:30 to 19:30

Networking zone 2 (N2)

Gabi Becker

Challenges for harm reduction II

18:30 to 19:30

Insights zone 3 (I3)

Alessandro Pirona

Friday, 25 October

10:45

Opioid-related deaths: learning from epidemiological studies

10:45 to 12:15

Insights zone 3 (I3)

Sarah Welch

Therapeutic horizons II

10:45 to 12:15

Central square 1 (C1)

Felix Carvalho

Presentations

Plenary session
Poster session
Big debate
Structured session
Workshop
Oral presentation session
Short communication session
Poster guided tour

Wednesday, 23 October

10:50

Poster

Exposure to alcohol and/or cadmium changes status of bioelements in rat tests

10:50 to 12:20

Guided poster tours room

Mirjana Djukic

Poster

'Drink to forget' – a case report

10:50 to 12:20

Guided poster tours room

Mariana Lázaro

Poster

Screening for alcohol-related cognitive impairments – a case study

10:50 to 12:20

Guided poster tours room

Luisa Gil

Poster

Neuroprotective role of argan oil against alcohol use disorders in adolescent wistar rat

10:50 to 12:20

Guided poster tours room

Hicham El Mostafi

Poster

Cadmium and/or ethanol increase oxidative stress in liver of the exposed rats

10:50 to 12:20

Guided poster tours room

Mirjana Djukic

Poster

Screening and brief interventions for reducing alcohol consumption in a department of firefighters in the central region of Portugal

10:50 to 12:20

Guided poster tours room

Teresa Barroso

Poster

Court proceedings and actions taken by a probation officer in work with people addicted to alcohol.

10:50 to 12:20

Guided poster tours room

Ewelina Silecka-Marek

Poster

Elderly wellbeing and alcohol - a tricky cocktail

10:50 to 12:20

Guided poster tours room

Jakob Emiliussen

11:00

Short communication

Portuguese gender-sensitive harm reduction services: bridging the gap

11:00 to 11:10

Networking zone 3 (N3)

Oral presentation

Vital signs: the future of the harm reduction model in the National Health Service

Are we addressing alcohol-attributable deaths?

11:00 to 11:15

Central square 2 (C2)

Francisco Goiana-da-Silva

11:10

Short communication

A change in the prescribing practice of prebagalin that has had a direct negative effect on drug-induced deaths in Ireland

11:10 to 11:20

Networking zone 3 (N3)

Ena Lynn

11:15

Oral presentation

Harm reduction and public health: the case of Sweden

The long-term impact of the Israeli national program to reduce alcohol problem drinking among children and youth: a nine-year follow-up 2010-2019

11:15 to 11:30

Central square 2 (C2)

Yossi Harel-Fisch

11:30

Short communication

Performance enhancing drugs. Results from a Belgian survey on PED use among workers

11:30 to 11:40

Networking zone 3 (N3)

Marie-Claire Lambrechts

Oral presentation

Harm reduction drug policy in Israel: what has and still needs to be accomplished?

Frequency of drinking in Europe and interplay between cultural and individual values

11:30 to 11:45

Central square 2 (C2)

11:40

Short communication

Drug and alcohol treatment: how much does it cost in Europe?

11:40 to 11:50

Networking zone 3 (N3)

Claudia Costa Storti

11:45

Oral presentation

Street Support Project: a harm reduction approach to urban health and integration

Associations between negative life events and adolescent alcohol/drug-related problems, and the potential moderating role of individual and social resilience factors. The youth@hordaland-survey

11:45 to 12:00

Central square 2 (C2)

Ove Heradstveit

11:50

Short communication

Young people's exposure to gambling advertisements: a mixed methods study in Australia.

11:50 to 12:00

Networking zone 3 (N3)

Hannah Pitt

12:00

Short communication

Street Work Nursing as an innovative strategy in the care for dually diagnosed individuals: reflections on a pilot study

12:00 to 12:10

Networking zone 3 (N3)

Ilse Goethals

12:10

Short communication

Dissuasion, the effectiveness of the intervention and good practices

12:10 to 12:20

Networking zone 3 (N3)

Américo Gegaloto

13:30

Short communication

Smokeless tobacco (snus) use and intergenerational social mobility among adolescents during 10 years

13:30 to 13:40

Networking zone 4 (N4)

Short communication

Treating drug abuse and health issues in the criminal justice system. An empirical research on the linkage of health and criminal justice interventions, France

13:30 to 13:40

Networking zone 3 (N3)

Ivana Obradovic

Short communication

Perceptions on social determinants of opioid dependence recovery

13:30 to 13:40

Networking zone 3 (N3)

Leonor Brito

Oral presentation

Substance Use Sex Index (SUSI): towards a new behaviour change assessment tool

13:30 to 13:45

Networking zone 2 (N2)

Nadine Ezard

13:40

Short communication

Transitions in smoking and nicotine use from 2016 to 2017 among a UK cohort of past-year smokers

13:40 to 13:50

Networking zone 4 (N4)

Erikas Simonavicius

Short communication

Reverse transition from injecting to smoking heroin and/or crack cocaine on lower methadone dose: sub-therapeutic dosing or safer drug use?

13:40 to 13:50

Networking zone 3 (N3)

Felicia Heidebrecht

13:45

Oral presentation

Chemsex experiences: pleasures, harms and care

13:45 to 14:00

Networking zone 2 (N2)

Maitena Milhet

13:50

Short communication

Co-use and co-quitting: predicting motivation to quit tobacco and cannabis among further education college students in the UK

13:50 to 14:00

Networking zone 4 (N4)

Hannah Walsh

Short communication

Benzodiazepine management in primary care: barriers and facilitators

13:50 to 14:00

Networking zone 3 (N3)

Kristien Coteur

14:00

Short communication

Implementation of financial incentives for successful smoking cessation in real-life company settings

14:00 to 14:10

Networking zone 4 (N4)

Gera Nagelhout

Oral presentation

The counselors’ perspective on the use of methamphetamine in a sexual context among men who have sex with men

14:00 to 14:15

Networking zone 2 (N2)

Valérie Aubut

Short communication

Referral of European and third country non-national clients in Belgian drug treatment

14:00 to 14:15

Networking zone 3 (N3)

Eva Blomme

14:10

Short communication

Challenges in tobacco control in Serbia

14:10 to 14:20

Networking zone 4 (N4)

Biljana Kilibarda

Short communication

HIV and drug abuse: relationship and treatment challenges

14:10 to 14:20

Networking zone 3 (N3)

Sara Dehanov

14:15

Oral presentation

Faster, higher, stronger? Results from a Belgian survey on PED use among gym-goers

14:15 to 14:30

Networking zone 2 (N2)

Bertrand Fincoeur

14:20

Short communication

Motivation for treatment predict adherence to treatment in a randomised clinical trial

14:20 to 14:30

Networking zone 3 (N3)

Zhanna Gaulen

14:30

Short communication

Psychiatric assessment of prisoners in opioid-maintenance treatment: emphasis on ADHD

14:30 to 14:40

Networking zone 3 (N3)

Marisa Silbernagl

14:40

Short communication

Perceptions on social determinants of opioid dependence recovery

14:40 to 14:50

Networking zone 3 (N3)

15:00

Oral presentation

The contribution of injecting drug use as a risk factor for Hepatitis C virus transmission globally, regionally, and at country level: a modelling study

Safe Injection Facilities Zurich - 30 years of experience

15:00 to 16:30

Networking zone 2 (N2)

Janine Lanz

Oral presentation

Implementation of a drug consumption room: conflict management - case analysis and success factors

15:00 to 16:30

Networking zone 2 (N2)

Simon WeisFlorian Meyer

Oral presentation

Security, Intervention, Prevention (SIP Zurich): conflicts of use in public spaces:

15:00 to 16:30

Networking zone 2 (N2)

Mara Brügger

15:15

Oral presentation

Factors associated with HIV and hepatitis C in the context of routes of drug administration among problem drug users in Latvia, 2018

15:30

Barriers in the treatment of HCV infection in drug users: inspiring solutions from SCUDO project

15:45

HCV care in an opiate substitution therapy program: assessment of infection, liver-related damage, and treatment rates.

16:00

Slamming, drug injection in sexual contexts: increased HIV and HCV exposure for MSM points to a need for intersectional approaches to harm reduction

16:00 to 16:15

Insights zone 3 (I3)

Marie Jauffret-Roustide

16:15

Oral presentation

Hepatitis C virus reinfection following antiviral treatment among people who inject drugs: a systematic review and meta-analysis

17:00

Harm reduction in drug addiction with special emphasis on women

17:15

New data support reduced alcohol consumption as harm reduction strategy in individuals with alcohol dependence

17:30

e-cigarettes as harm reduction in smokers, what is the evidence?

17:45

Discussant

18:30

The peer in outreach teams: a specialist among specialists?

18:30 to 18:40

Networking zone 3 (N3)

Maria João Oliveira

Oral presentation

Acceptability and willingness to use a mobile drug consumption room in Lisbon

18:40

The Akan-model: a Norwegian model for preventing and handling alcohol, drugs and gambling problems in the workplace

18:40 to 18:50

Networking zone 3 (N3)

Camilla Lynne Bakkeng

18:45

Oral presentation

Drug consumption rooms – from a conceptual framework to a basic institutionalised service. The experience of Germany

18:50

Experiences of marketised welfare organisations among addiction treatment staff in Sweden

18:50 to 19:00

Networking zone 3 (N3)

Jessica Storbjörk

19:00

Short communication

Preparing effective addiction workforce: a challenge from the Czech perspective

19:00 to 19:10

Networking zone 3 (N3)

Amalie Pavlovská

Oral presentation

How to develop a common adherence of all the stakeholders when implementing a drug consumption room?

19:10

Workforce development: the great paradox for the addictions sector

19:10 to 19:20

Networking zone 3 (N3)

Ann Roche

19:15

Oral presentation

Against political odds: the establishment of a drug consumption room in Belgium.

19:20

Evidence-based practice and its many competing priorities: a qualitative analysis of substance misuse workers in English third-sector addiction treatment services

19:20 to 19:30

Networking zone 3 (N3)

Robert Calder

Thursday, 24 October

10:50

Oral presentation

Drug related interventions in European prisons: provision, available evidence, gaps

Evidence and evidence-based interventions for people with drug related problems in prison settings

Implementation of harm reduction interventions in prison: what are the challenges

The first therapeutic community in French prisons: review and prospects

Evidence and practice: what are the challenges that drug professionals working in prison have to face

Alcohol addiction as a social problem in Ukraine: history of research

10:50 to 12:20

Guided poster tours room

Larysa Klymanska

Poster

The alcohol consumption in the modern Ukraine: tendences and perspecties.

10:50 to 12:20

Guided poster tours room

Larysa Klymanska

Poster

Alcohol and drugs in contemporary school pupils on the verge of adolescence: the Polish experience

10:50 to 12:20

Guided poster tours room

Katarzyna Pawelek

Poster

The role of alcohol in fatal fires in Ireland

10:50 to 12:20

Guided poster tours room

Anne Doyle

Poster

Do parents want to change alcohol legislations to protect their children?

10:50 to 12:20

Guided poster tours room

Marta Zin-Sedek

Poster

Social and context determinants of drinking during working time – Portuguese GPS findings 2017

10:50 to 12:20

Guided poster tours room

Cláudia Urbano

Poster

Sub-groups of tobacco and alcohol co-use trajectories from ages 21 to 32: the Amsterdam growth and health longitudinal study

10:50 to 12:20

Guided poster tours room

Sterling McPherson

Poster

Effects of an alcohol prevention program at sport stadiums: a 2-year follow-up study using pseudopatrons and breath alcohol concentration levels

10:50 to 12:20

Guided poster tours room

Tobias Elgan

Poster

Implementing and evaluating alcohol and drug prevention methods at youth health clinics

10:50 to 12:20

Guided poster tours room

Pia Kvillemo

Poster

Accessing alcohol drinking influence in workplace – What is the panorama and current innovations in Portugal?

10:50 to 12:20

Guided poster tours room

Duarte Vital Brito

11:00

Short communication

Quantitative and qualitative evidences for better gender-based prevention of adolescent addictive behaviours, with and without substance

11:00 to 11:10

Networking zone 4 (N4)

Patricia Gómez

Oral presentation

Psychiatric comorbidity and intimate partner violence among women who inject drugs in Europe: a cross-sectional study

11:00 to 11:15

Central square 3 (C3)

Judit Tirado-Muñoz

Oral presentation

An interactive training session

11:00 to 11:15

Networking zone 2 (N2)

Richard Stranz

11:10

Short communication

The European Web Survey on Drugs: patterns of use of new psychoactive substances in Belgium

11:10 to 11:20

Networking zone 4 (N4)

Lies Gremeaux

11:15

Oral presentation

A gendered approach to women’s lived experiences of gambling harm: preliminary findings

11:15 to 11:30

Central square 3 (C3)

Simone McCarthy

Oral presentation

Experiences from the field

11:15 to 11:30

Networking zone 2 (N2)

Joana Pires

11:20

Short communication

From chronology to processes: combining biographical interview with episodic analysis in a life story

11:20 to 11:30

Networking zone 4 (N4)

Isabel María Herrera-Sánchez

11:30

Short communication

Coding multiple drug use in ICD-10 and ICD-11

11:30 to 11:40

Networking zone 4 (N4)

Espen Walderhaug

Oral presentation

How can partners influence the gambling habits of their gambler spouse?

11:30 to 11:45

Central square 3 (C3)

Melissa Cote

Oral presentation

The researcher perspective

11:30 to 11:45

Networking zone 2 (N2)

Perrine Roux

11:40

Short communication

The scientific portrayal of decriminalisation models for psychoactive substances: a scoping review

11:40 to 11:50

Networking zone 4 (N4)

Isabel María Herrera-Sánchez

Short communication

The scientific portrayal of decriminalisation models for psychoactive substances: a scoping review

11:40 to 11:50

Networking zone 4 (N4)

Daniela Filipa Ferreira

11:45

Oral presentation

Methamphetamine use during pregnancy and weak evidence of adverse neonatal outcomes

11:45 to 12:00

Central square 3 (C3)

Roman Gabrhelik

Oral presentation

The importance of advocacy

11:45 to 12:00

Networking zone 2 (N2)

Eberhard Schatz

11:50

Short communication

The role of the juveniles in the structure and dynamics of the illegal drug market in the Republic of Croatia

11:50 to 12:00

Networking zone 4 (N4)

12:00

Short communication

Lifetime prevalence of drug use before imprisonment in Europe: results from a systematic literature review

12:00 to 12:10

Networking zone 4 (N4)

12:10

Short communication

Public participation in effective development of a regional drug strategy: experiences from the South East region of Ireland

12:10 to 12:20

Networking zone 4 (N4)

Michelle Foley

13:30

Short communication

Nurse-delivered injection education and subsequent injection drug use practices among street-involved youth

13:30 to 13:40

Networking zone 3 (N3)

Andreas Pilarinos

Oral presentation

Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England

13:30 to 13:45

Central square 2 (C2)

John Marsden

Oral presentation

Development of lower-risk gambling guidelines

The off-prescription use of modafinil: an online survey of perceived risks and benefits

13:40

The impact of abused drugs spectrum among romanina IDU's on STI's, TB and blood born diseases in the last 10 years

13:40 to 13:50

Networking zone 3 (N3)

Adrian Abagiu

13:45

Oral presentation

Results of mortality cohort study of problem drug users in Poland.

13:45 to 14:00

Central square 2 (C2)

Janusz Sieroslawski

Oral presentation

Couple treatment of pathological gambling: variables associated with better efficacy

Prospective cohort to assess the impact of removing non-prescription codeine in Australia

13:50

Zero new infections of HIV among PWID, 4 consecutive years, a reality in Macau

13:50 to 14:00

Networking zone 3 (N3)

Augusto Nogueira

14:00

Short communication

Theory versus practice, bacteriological efficiency versus personal habits. A bacteriological and user acceptability evaluation of filtering tools for people who inject drugs.

14:00 to 14:10

Networking zone 3 (N3)

Marie Jauffret-Roustide

Oral presentation

Coping strategies and dysfunctional symptomatoly in pathological gamblers.

Characteristics and problematic opioid use in people prescribed opioids for CNCP over four years: a prospective cohort study

Nasal naloxone for overdose prevention in Norway: results from the first four years

14:00 to 14:15

Central square 2 (C2)

Oral presentation

Nasal naloxone for overdose prevention in Norway: results from the first four years

14:00 to 14:15

Central square 2 (C2)

Desiree Eide

14:10

Short communication

C+ |Be+| Be your rights... an example of community mobilisation in a neighborhood with an open scene of drug consumption in Porto.

14:10 to 14:20

Networking zone 3 (N3)

Rui Miguel Coimbra Morais

14:15

Oral presentation

Incidence and predictors of drug overdoses among a cohort of patients treated for substance use disorder

14:15 to 14:30

Central square 2 (C2)

Birgitte Thylstrup

Oral presentation

A qualitative study of gabapentin use and misuse: perspectives of substance abuse treatment professionals

Determinants for the effectiveness of an Online Ambulatory Service for Internet Addicts (OASIS)

14:20

Innovative practices in harm reduction outreach teams in the city of Lisbon

14:20 to 14:30

Networking zone 3 (N3)

Inês CostaCristiana Merendeiro

14:30

Oral presentation

MDMA-related deaths in Australia

14:30 to 14:45

Central square 2 (C2)

Amanda Roxburgh

15:00

Poster

Dosing of naloxone in opioid overdose outside of hospital. Observational data 2014 -18 in Oslo, Norway

15:00 to 16:30

Guided poster tours room

Ida Tylleskär

Poster

Increasing trend and differential patterns of opioids prescribing by patient characteristics in primary care in Belgium: a registry-based study

15:00 to 16:30

Guided poster tours room

Catharina Matheï

Poster

Patterns in analgesic opioids use in Germany and France: improved pain management and risks of misuse

15:00 to 16:30

Guided poster tours room

Jessica Neicun

Poster

Barriers to establishing take-home naloxone programmes

15:00 to 16:30

Guided poster tours room

Sibella Hare Breidahl

Poster

Patient characteristics and expected needs: an opioid substitution programme findings

15:00 to 16:30

Guided poster tours room

Catarina Oliveira

Poster

Benzodiazepine use among patients in opioid substituttion treatment: a cross sectional study

15:00 to 16:30

Guided poster tours room

Catarina Oliveira

Poster

Hospitalisation of children after prenatal exposure to Methadone and Buprenorphine: national registry study from Czechia

15:00 to 16:30

Guided poster tours room

Blanka Nechanská

Poster

Uncovering trajectories of satisfaction with injectable opioid agonist treatment for severe opioid use disorder

15:00 to 16:30

Guided poster tours room

Kirsten Marchand

Poster

Predicting pain intensity following discontinuation of long-term opioid therapy among patients with and without substance use disorders

15:00 to 16:30

Guided poster tours room

Crystal Smith

Poster

Addressing the opioid crisis: engagement in multidisciplinary care

15:00 to 16:30

Guided poster tours room

Tianna Magel

Poster

Comparing rates and characteristics of harms across different pharmaceutical opioids: an examination of Australian ambulance attendances 2013-2018

15:00 to 16:30

Guided poster tours room

Tina Lam

15:10

Short communication

Psychedelic-assisted psychotherapy for the treatment of addictions: The future of addiction treatment?

15:10 to 15:20

Networking zone 3 (N3)

Anton Gomez-Escolar

Oral presentation

Predictive analysis of alcohol consumption and stress through the psychosocial variables of emotional intelligence and resilience

15:10 to 15:25

Central square 3 (C3)

Filipa Coelhoso

15:20

Short communication

Drug addiction in the immigrant population of users undergoing the low-threshold methadone maintenance programme in Lisbon

15:20 to 15:30

Networking zone 3 (N3)

Hugo Faria

15:25

Oral presentation

Harmful alcohol use among acutely ill hospitalised medical patients

15:25 to 15:40

Central square 3 (C3)

Saranda Kabashi

15:30

Short communication

Employment influence in recovering people who use drugs during opiate substitution treatment

15:30 to 15:40

Networking zone 3 (N3)

Ângela Leite

15:40

Short communication

Working with complex families with parental substance abuse: an overview of the parents under pressure program

15:40 to 15:50

Networking zone 3 (N3)

Sharon Dawe

Oral presentation

Somewhere to be: the spatiality’s of alcohol abuse and recovery in a non-interventionist, peer led centre.

15:40 to 15:55

Central square 3 (C3)

Kirstie Soar

17:00

Oral presentation

Interpreting wastewater data alongside other population-level indicators of stimulant use

17:00 to 17:15

Central square 2 (C2)

Hayley Jones

Oral presentation

Informal social support as a crucial factor in recovery from drug misuse

17:15

What are the indirect causes of death among people who use drugs in Ireland? Findings from a comprehensive special register on drug related deaths

17:15 to 17:30

Central square 2 (C2)

Suzi Lyons

Oral presentation

Social and professional integration, addictive behaviours and time perspectives: personal experiences of young adults involved in a low-threshold employment program in Montreal

17:30

Temporary and constant remission: a record-linkage study of a national cohort of people with psychoactive drug use disorders

17:30 to 17:45

Central square 2 (C2)

Morten Hesse

Oral presentation

General practice patients in treatment for substance use problems at different levels of care: an observational study using two data sources

17:45

Effective policies to support autonomous attempts to quit opioid use - a cross-sectional study across 14 countries

17:45 to 18:00

Central square 2 (C2)

Larissa Maier

Oral presentation

The Healthy Addiction Treatment (HAT) recovery model for addiction nursing services

18:00

'Once a drug addict, always a drug addict': the role of stigma in recovery

18:30

Re-emergence of injecting drug use-related HIV despite a comprehensive harm reduction environment

New HCV prevention strategies and tools: lessons learnt

18:30 to 19:50

Networking zone 2 (N2)

Eberhard SchatzGabi Becker

18:40

Short communication

Opioid-related problems in Baltic States and Poland: has the turning point come?

18:40 to 18:50

Networking zone 4 (N4)

Katri Abel-Ollo

Short communication

Recommendations for NPS-targeted initiatives in Belgium

18:40 to 18:50

Networking zone 3 (N3)

Anton van Dijck

18:45

Oral presentation

Amphetamine-type stimulant use: global and European trends in the harm reduction response

18:50

Estonia’s fentanyl battle: time to scale-up overdose prevention strategy?

18:50 to 19:00

Networking zone 4 (N4)

Sibella Hare Breidahl

Short communication

Predicting the onset of ketamine use among frequent nightlife attendees

18:50 to 19:00

Networking zone 3 (N3)

Charlotte van Miltenburg

Oral presentation

HCV prevention — moderated exchange

18:50 to 19:10

Networking zone 2 (N2)

Christine Rolle

19:00

Short communication

Assessment of possibilities for raising the quality of health care provided to opioid users by increasing access to substitution treatment

19:00 to 19:10

Networking zone 4 (N4)

Boguslawa Bukowska

Short communication

Why a zero tolerance drug policy for festivals is not working (well)

19:00 to 19:10

Networking zone 3 (N3)

Jochen Schrooten

Oral presentation

Implementation of an educational intervention for safer injection in the European context: preliminary results from the EUROSIDER project

19:10

Rising incidence of ageing opioid users within the EU wide treatment

19:10 to 19:20

Networking zone 4 (N4)

Anne Marie Carew

Short communication

Towards gender-sensitive responses in the drugs field: Intersections between sexual violence, drug use in nightlife environments

19:10 to 19:20

Networking zone 3 (N3)

Cristiana Vale Pires

Oral presentation

Short presentation of developed materials and training curricula of Integrative Drogenhilfe

19:10 to 19:20

Networking zone 2 (N2)

Christine Rolle

19:20

Short communication

Setting up a HPLC in a 7-day psychedelic music festival: drug checking moving forward

19:20 to 19:30

Networking zone 3 (N3)

Daniel Martins

Oral presentation

HCV prevention — moderated discussion

19:20 to 19:30

Networking zone 2 (N2)

Gabi Becker

Short communication

The neglected public health problem of opioid use among offenders - why we have failed and where we can improve.

19:20 to 19:30

Networking zone 4 (N4)

Friday, 25 October

10:55

Oral presentation

Memory-focused cognitive therapy for cocaine use disorder: theory, procedures and preliminary evidence from an external pilot randomised controlled trial

10:55 to 11:10

Central square 1 (C1)

John Marsden

Oral presentation

Overdose deaths in people prescribed opioids for chronic non-cancer pain: Systematic review and meta-analysis

11:10

Treatment of youth with substance use disorder and co-existing mental disorder: the MOVE programme.

11:10 to 11:25

Central square 1 (C1)

Mads Uffe Pedersen

Oral presentation

Hidden aspects of the opioid crisis: what factors are driving ageing trends among those using opioid drugs?

11:25

The impact of maternal alexithymia on parenting behaviours in the context of substance use disorders

11:25 to 11:40

Central square 1 (C1)

Alessio Porreca

Oral presentation

Comparing rates and characteristics of harms across different pharmaceutical opioids: an examination of Australian ambulance attendances 2013-2018.

11:40

The role of social environment in pathways to recovery: a scoping review

11:40 to 11:55

Central square 1 (C1)

João Pedro Ramos

Oral presentation

Causes of death among patients in opioid maintenance treatment in Norway

11:55

Increased risk of HIV and other drug-related harms associated with injecting in public places: national bio-behavioural survey of people who inject drugs

11:55 to 12:10

Insights zone 3 (I3)

Kirsten Trayner